UTHR vs. BBH
Compare and contrast key facts about United Therapeutics Corporation (UTHR) and VanEck Vectors Biotech ETF (BBH).
BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: UTHR or BBH.
Correlation
The correlation between UTHR and BBH is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
UTHR vs. BBH - Performance Comparison
Key characteristics
UTHR:
2.33
BBH:
-0.28
UTHR:
3.05
BBH:
-0.27
UTHR:
1.43
BBH:
0.97
UTHR:
2.62
BBH:
-0.15
UTHR:
12.20
BBH:
-0.81
UTHR:
5.34%
BBH:
5.60%
UTHR:
27.95%
BBH:
16.35%
UTHR:
-93.18%
BBH:
-72.69%
UTHR:
-11.80%
BBH:
-26.38%
Returns By Period
In the year-to-date period, UTHR achieves a 2.49% return, which is significantly higher than BBH's 1.59% return. Over the past 10 years, UTHR has outperformed BBH with an annualized return of 9.89%, while BBH has yielded a comparatively lower 3.21% annualized return.
UTHR
2.49%
-3.00%
9.11%
65.34%
31.31%
9.89%
BBH
1.59%
-1.67%
-9.77%
-3.86%
3.06%
3.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
UTHR vs. BBH — Risk-Adjusted Performance Rank
UTHR
BBH
UTHR vs. BBH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
UTHR vs. BBH - Dividend Comparison
UTHR has not paid dividends to shareholders, while BBH's dividend yield for the trailing twelve months is around 0.78%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BBH VanEck Vectors Biotech ETF | 0.78% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
Drawdowns
UTHR vs. BBH - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, which is greater than BBH's maximum drawdown of -72.69%. Use the drawdown chart below to compare losses from any high point for UTHR and BBH. For additional features, visit the drawdowns tool.
Volatility
UTHR vs. BBH - Volatility Comparison
United Therapeutics Corporation (UTHR) has a higher volatility of 8.41% compared to VanEck Vectors Biotech ETF (BBH) at 5.37%. This indicates that UTHR's price experiences larger fluctuations and is considered to be riskier than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.